IDEXX Laboratories Boosts 2026 Financial Outlook After Strong Q3

AI-generated NewsSnap summary based on source reporting.
Published: 2026-11-02T11:55:00Z
Category: business
Source: Stock Titan
Original source

IDEXX Laboratories reported third-quarter revenue of $1,214 million, exceeding expectations. Following these strong results, the company has raised its revenue and earnings per share (EPS) outlook for the full year 2026. This indicates robust financial performance and positive future projections for the veterinary diagnostics firm.

Want more?

Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.

Open NewsSnap.ai